Vaxcyte PCVX 深 滬
等待開盤 01-12 09:30:00 美东时间
46.05
+0.730
+1.61%
華盛通- 最 高47.72
- 今 開46.05
- 成交量 79.53万股
- 最 低 45.74
- 昨 收 45.32
- 總市值 60.33亿
- 52周最高 93.77
- 市盈率 靜 --
- 換手率 0.61%
- 52周最低 27.66
- 委 比 -64.02%
- 總股本 1.31亿
- 歷史最高 121.055
- 量 比 0.63
- 振 幅 4.37%
- 歷史最低 15.51
- 每 手 1
- 風險率 18.95%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
Needham Maintains Buy on Vaxcyte, Raises Price Target to $110
Needham analyst Joseph Stringer maintains Vaxcyte (NASDAQ:PCVX) with a Buy and raises the price target from $90 to $110.
01-07 19:23
FDA承诺实施新疫苗要求，莫德纳股价下跌
美国食品药品监督管理局（FDA）在上周末的一份备忘录中表示，将对获批上市的疫苗实施新限制措施，受此影响，莫德纳公司（Moderna Inc．）股价于周一下跌...
2025-12-01 23:50
CleanSpark, Cipher Mining, Bitdeer Technologies And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around...
2025-12-01 21:43
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
2025-11-11 10:49
BTIG Reiterates Buy on Vaxcyte, Maintains $85 Price Target
BTIG analyst Thomas Shrader reiterates Vaxcyte (NASDAQ:PCVX) with a Buy and maintains $85 price target.
2025-11-10 18:31
Vaxcyte GAAP EPS of -$1.56 misses by $0.25
Vaxcyte press release (PCVX): Q3 GAAP EPS of -$1.56 misses by $0.25. Ending the third quarter with $2.7 billion in cash, cash equivalents and investments. More on Vaxcyte Vaxcyte, Inc. (PCVX) Presents...
2025-11-05 06:23
Vaxcyte Q3 EPS $(1.56) Misses $(1.30) Estimate
Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(1.56) per share which missed the analyst consensus estimate of $(1.30) by 19.82 percent. This is a 87.95 percent decrease over losses of $(0.83) per share from the
2025-11-05 05:47
ClearBridge SMID Cap Growth Strategy
The ClearBridge SMID Cap Growth Strategy underperformed its Russell 2500 Growth Index benchmark during the third quarter, with the index gaining 10.7%. As such, the performance of SMID growth equitie...
2025-10-13 23:15
Thermo Fisher Scientific prices $2.5B senior notes
Thermo Fisher Scientific (NYSE:TMO) priced an offering of $2.5B senior notes consiting of: $500M 4.200% senior notes due 2031 at the issue price of 99.874%; $750M 4.473% senior notes due 2032 at the...
2025-10-01 13:28
